Mayne Pharma (MYX) is a pharmaceutical company focused on commercialising branded women's health and dermatology pharmaceuticals. Mayne Pharma has a 40 year track record of innovation and success in developing new oral drug delivery systems and these technologies have been commercialised in products that continue to be marketed around the world. Mayne Pharma has formulation of complex oral and topical dose forms including release products and poorly soluble compounds.